Effect of CPAP Treatment on the Elderly With Mild to Moderate Sleep Apnea

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03079466

Enrollment

Registered

2017-03-14

Start date

2017-03-09

Completion date

2017-07-15

Last updated

2017-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unrecognized Condition

Keywords

Sleep apnea, Elderly, CPAP

Brief summary

Objective: To analyze the impact of CPAP treatment on cognitive, clinical and quality of life domains in patients over 70 years of age with mild-to-moderate OSA Primary Outcome: Epworth scale and QSQ domains Secondary Outcomes: Neurocognitive variables and CPAP adherence

Interventions

OTHERCPAP

This is a randomized study where patients are included consecutively under a randomization order that will be given to the investigators. Patients will continue to be treated with CPAP and other treatment with no CPAP for a duration of 3 months and with intention-to-treat analysis And by protocol.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Intervention model description

Randomized clinical trial

Eligibility

Sex/Gender

ALL

Age

70 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Age equal or greater than 70 years of both sexes * Patients with sleep study results with AHI ≥ 15 and \< 30

Exclusion criteria

* Alternative diagnoses of other non-respiratory sleep disorders that are also cause of pathological somnolence (eg, sdr restless legs, narcolepsy, etc.) * Don't sign informed consent * Acute or chronic respiratory insufficiency requiring home oxygen therapy * Patients with Obesity Hypoventilation Syndrome * Diagnosis of neuro-psychiatric diseases with the exception of anxiety - depression or diagnosis of dementia. * Diseases of any origin in the acute phase * Heart failure or recent stroke (less than 3 months). * Central SAHS (more than 50% of the registry with central apneas or Cheyne-Stokes breathing) * Pre-treatment with CPAP * Inability to perform the diagnostic study of sleep due to the patient's condition * Hipersomniaincapacitante (Epworth≥18) with no known or most likely cause related to SAHS

Design outcomes

Primary

Measure	Time frame	Description
Epworth Sleepiness Scale	3 months	Measure of diurnal sleepiness
Quebec Sleep Questionnaire domains	3 months	Quality of Life measured in sleep apnea patients

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026